These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3063728)

  • 1. A comparison of carteolol and nadolol in the treatment of stable angina pectoris.
    Luther RR; Glassman HN; Jordan DC
    J Clin Pharmacol; 1988 Jul; 28(7):634-9. PubMed ID: 3063728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of angina pectoris with the new beta-receptor blocker carteolol. Results of a controlled trial in comparison with pindolol.
    Simon H; Schuppan U
    Arzneimittelforschung; 1983; 33(2a):318-21. PubMed ID: 6340700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agent.
    Luther RR; Glassman HN; Jordan DC; Klepper MJ
    J Int Med Res; 1986; 14(4):167-74. PubMed ID: 3093295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of nadolol, a new long-acting beta-receptor blocking agent, and placebo in the treatment of stable angina pectoris.
    Shapiro W; Park J; DiBianco R; Singh SN; Katz RJ; Fletcher R
    Chest; 1981 Oct; 80(4):425-30. PubMed ID: 6791883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experiences in patients with coronary heart disease and angina pectoris].
    Sölter H
    Arzneimittelforschung; 1983; 33(2a):304-10. PubMed ID: 6404286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nadolol compared to propranolol for treating chronic stable angina pectoris.
    Miller LA; Crawford MH; O'Rourke RA
    Chest; 1984 Aug; 86(2):189-93. PubMed ID: 6146499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of bepridil with nadolol for angina pectoris.
    Pflugfelder PW; Humen DP; O'Brien PA; Purves PD; Jablonsky G; Kostuk WJ
    Am J Cardiol; 1987 Jun; 59(15):1283-8. PubMed ID: 3296724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparative study of carteolol and propranolol on exercise performance in patients with chronic stable angina pectoris].
    Liu PH; Lai WY; Chen CY; Shieh SM
    Taiwan Yi Xue Hui Za Zhi; 1985 Apr; 84(4):457-61. PubMed ID: 3860617
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the duration of action of atenolol and nadolol for treatment of angina pectoris.
    Kostis JB
    Am J Cardiol; 1988 Dec; 62(17):1171-5. PubMed ID: 3057850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nadolol versus diltiazem and combination for preventing exercise-induced ischemia in severe angina pectoris.
    Miller WE; Vittitoe J; O'Rourke RA; Crawford MH
    Am J Cardiol; 1988 Sep; 62(7):372-6. PubMed ID: 3414514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation, by the bicycle ergometry test ECG, of the efficacy of a single dosage of nadolol, in patients with stable angina pectoris].
    Capuano V; De Vita S; Riccio MD; De Martino M; Mondillo G
    Minerva Cardioangiol; 1985 Nov; 33(11):739-44. PubMed ID: 2868431
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term double-blind evaluation of amlodipine and nadolol in patients with stable exertional angina pectoris. The Investigators of Study 152.
    Singh S
    Clin Cardiol; 1993 Jan; 16(1):54-8. PubMed ID: 8416762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiorespiratory effects of isosorbide dinitrate and nifedipine in combination with nadolol: a double-blind comparative study of beneficial and adverse antianginal drug interactions.
    Tirlapur VG; Mir MA
    Am J Cardiol; 1984 Feb; 53(4):487-92. PubMed ID: 6141727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect].
    Kober G; Veidt J; Mikludy R; Kaltenbach M
    Arzneimittelforschung; 1983; 33(2a):313-7. PubMed ID: 6682323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.
    Frishman W; Charlap S; Kimmel B; Teicher M; Cinnamon J; Allen L; Strom J
    Circulation; 1988 Apr; 77(4):774-86. PubMed ID: 3280158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angina pectoris: effective therapy once daily.
    Prager G
    J Int Med Res; 1979; 7(1):39-44. PubMed ID: 33863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.
    DiBianco R; Morganroth J; Freitag JA; Ronan JA; Lindgren KM; Donohue DJ; Larca LJ; Chadda KD; Olukotun AY
    Am Heart J; 1984 Oct; 108(4 Pt 2):1121-7. PubMed ID: 6148872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.
    Jones GR; Mir MA
    Br Heart J; 1981 Nov; 46(5):503-7. PubMed ID: 6119104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
    Brügmann U; Blasini R
    Herz; 1986 Feb; 11(1):55-61. PubMed ID: 2870014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris.
    Furberg B; Dahlqvist A; Raak A; Wrege U
    Curr Med Res Opin; 1978; 5(5):388-93. PubMed ID: 26520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.